Legislation introduced in Washington would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy.

Introduction of legislation to eliminate out-of-pocket costs for medically necessary diagnostic and supplemental imaging could make care more affordable and accessible to women in New Mexico.

Susan G. Komen® Commends Bill Introduction; Urges Quick Passage ST. LOUIS, MISSOURI – JANUARY 10, 2023 – Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Brenda Shields (R-St. Joseph) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the […]

Dr. Ann H. Partridge has been named Chief Scientific Advisor to Susan G. Komen where she’ll help lead Komen’s research investment and strategy.

Susan G. Komen raised $14 million from the 2022 3-Day event series and announced a new location for 2023.

Susan G. Komen advocates called on Congress to immediately pass the pending Metastatic Breast Cancer Access to Care Act to waive unnecessary and burdensome waiting periods for people with the disease to receive federal financial help.

The Nation’s First Pickleball Fundraising Activity Supporting Breast Cancer  Susan G. Komen®, the world’s leading breast cancer organization, announced a new, signature fundraising activity called Pickleball for the Cure.  To kick off Pickleball for the Cure, Komen is launching a national Pickleball Day Challenge to celebrate National Pickleball Day, Monday, August 8.  Participants will challenge […]

Susan G. Komen®, the world’s leading breast cancer organization, is awarding $21.7 million to fund 48 new research projects at 26 distinguished academic medical institutions in the U.S. that are focused on improving patient outcomes – particularly for people with the most aggressive breast cancers, or who have experienced a recurrence or metastasis. With this […]

A new study examining how to harness one’s immune system to eliminate metastatic breast cancer (MBC) tumors in the body is receiving a three-year $600,000 grant from Susan G. Komen®, the world’s leading breast cancer organization. This grant joins Komen’s active portfolio of over $65 million currently invested in metastatic breast cancer research. The pre-clinical […]